Advanced in WT1-Related Wilms Tumor Syndromes

Dr. Firas G. Petros

Urology
University Of Toledo Physicians LLC
1325 Conference Dr, 
Toledo, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Advanced in WT1-Related Wilms Tumor Syndromes
University Of Toledo Physicians LLC
1325 Conference Dr, 
Toledo, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Firas Petros is an Urologist in Toledo, Ohio. Dr. Petros is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Nephrectomy, and Ureteroscopy. Dr. Petros is currently accepting new patients.

His clinical research consists of co-authoring 56 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in TX
Hospital Affiliations
University Of Toledo Medical Center
Mercy St Vincent Medical Center
Promedica Toledo Hospital
Fulton County Health Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medical Mutual
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

UNIVERSITY OF TOLEDO PHYSICIANS LLC
1325 Conference Dr, Toledo, OH 43614

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)
Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)
Enrollment Status: Recruiting
Publish Date: September 09, 2025
Intervention Type: Drug, Procedure
Study Phase: Phase 3
A Phase III Double Blinded Study of Early Intervention After RADICAl ProstaTEctomy With Androgen Deprivation Therapy With or Without Darolutamide vs. Placebo in Men at Highest Risk of Prostate Cancer Metastasis by Genomic Stratification (ERADICATE)
A Phase III Double Blinded Study of Early Intervention After RADICAl ProstaTEctomy With Androgen Deprivation Therapy With or Without Darolutamide vs. Placebo in Men at Highest Risk of Prostate Cancer Metastasis by Genomic Stratification (ERADICATE)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Drug
Study Drugs: Darolutamide, Goserelin acetate, Leuprolide acetate, Triptorelin
Study Phase: Phase 3
A Phase 3 Study of Cretostimogene Grenadenorepvec in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus-Calmette-Guerin (BCG)
A Phase 3 Study of Cretostimogene Grenadenorepvec in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus-Calmette-Guerin (BCG)
Enrollment Status: Active_not_recruiting
Publish Date: July 03, 2025
Intervention Type: Other, Biological
Study Drugs: CG0070, N-Dodecyl-B-D-Maltoside
Study Phase: Phase 3
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Phase 3
View 3 Less Clinical Trials

56 Total Publications

Phimosis of foreskin uncovering schistosomiasis of the urinary bladder: a case report.
Phimosis of foreskin uncovering schistosomiasis of the urinary bladder: a case report.
Journal: Translational andrology and urology
Published: March 09, 2025
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Wassim M. Bazzi
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Wassim M. Bazzi
Urology

Michigan Institute Of Urology

18100 Oakwood Blvd., Suite 315, 
Dearborn, MI 
 (51.2 miles away)
313-271-0066
Languages Spoken:
English, Arabic, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Wassim Bazzi is an Urologist in Dearborn, Michigan. Dr. Bazzi is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Obstructive Uropathy, Hydronephrosis, Nephrectomy, and Ureteroscopy. Dr. Bazzi is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ganesh S. Palapattu
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ganesh S. Palapattu
Urology

Regents Of The University Of Michigan

19900 Haggerty Rd, Suite 111, 
Livonia, MI 
 (57.2 miles away)
734-936-7030
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ganesh Palapattu is an Urologist in Livonia, Michigan. Dr. Palapattu is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Palapattu is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael G. Rashid
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael G. Rashid
Urology

Promedica Genito-Urinary Surgeons LLC

2120 W Central Ave, 
Toledo, OH 
 (4.5 miles away)
419-531-8558
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Rashid is an Urologist in Toledo, Ohio. Dr. Rashid is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Urinary Tract Infection in Children, Ureteroscopy, and Nephrectomy. Dr. Rashid is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Petros's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile